Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227051 · ClinicalTrials.gov registry record · NA
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
A NA study of Obesity & Overweight and Obesity (Disorder), sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07227051: Recruiting NA study of Obesity & Overweight and Obesity (Disorder), sponsored by Wake Forest University Health Sciences.
NCT07227051 is a NA study of Obesity & Overweight and Obesity (Disorder) that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 300 participants, above the 104-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (188% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227051, a NA study of Obesity & Overweight and Obesity (Disorder), is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn how to best provide weekly feedback on individual progress toward intervention goals during a weight loss program.
Primary Outcome
Fitted model values will then be used to estimate the slope of weight change from day 1 (the day a feedback message is received) to day 7 of each week, with positive values representing weight gain and negative values representing weight loss.
Conditions Studied
Interventions
- BEHAVIORAL Feedback on Calorie Goal Attainment
- BEHAVIORAL Feedback on Dietary Quality
- BEHAVIORAL Feedback on Physical Activity Goal Attainment
- BEHAVIORAL Goal Setting Prompt
Study Locations (1)
Wisconsin
- Advocate Aurora Research Institute - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-01-26 |
| Est. Completion | 2028-02-28 |
| Phase | NA |
What NCT07227051 shows while recruiting
NCT07227051 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 104-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (188% higher).
The record links to 2 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 4 interventions - of which Feedback on Calorie Goal Attainment is the first listed.
NCT07227051 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07227051 about?
NCT07227051 is a clinical study titled "Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity". The purpose of this research study is to learn how to best provide weekly feedback on individual progress toward intervention goals during a weight loss program.
What is the current status of trial NCT07227051?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-01-26. Estimated completion is 2028-02-28.
What conditions does trial NCT07227051 study?
This clinical trial studies the following conditions: Obesity & Overweight, Obesity (Disorder).
What interventions are being tested in trial NCT07227051?
The interventions under investigation include: Feedback on Calorie Goal Attainment (BEHAVIORAL), Feedback on Dietary Quality (BEHAVIORAL), Feedback on Physical Activity Goal Attainment (BEHAVIORAL), Goal Setting Prompt (BEHAVIORAL).
Who is sponsoring clinical trial NCT07227051?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227051 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07227051's enrollment target sits among peer trials
300 2nd of 28 higher than 26 of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
-
FELLAShip to Better Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI